A. Stanley

Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk.

J. Dixon, P. Barrett-Lee, C. Palmieri, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines

H. Modjtahedi, G. H. Ashrafi, A. Seddon, 2017, Scientific Reports.